CATALYST PHARMACEUTICALS (CPRX) Covered Calls

CATALYST PHARMACEUTICALS covered calls Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical Company, focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy.

You can sell covered calls on CATALYST PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CPRX (prices last updated Wed 12:50 PM ET):

CATALYST PHARMACEUTICALS (CPRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.89 0.00 2.89 2.90 125K - 0.3B
Covered Calls For CATALYST PHARMACEUTICALS (CPRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 2.5 0.00 2.90 -13.8% -1679.0%
Sep 21 2.5 0.45 2.45 2.0% 19.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.